相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Telomere/telomerase interplay in virus-driven and virus-independent lymphomagenesis: pathogenic and clinical implications
Riccardo Dolcetti et al.
MEDICINAL RESEARCH REVIEWS (2012)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Telomerase activation without shortening of telomeric 3′-overhang is a poor prognostic factor in human colorectal cancer
Kensaku Kojima et al.
CANCER SCIENCE (2011)
The prognostic value of hTERT expression levels in advanced-stage colorectal cancer patients: a comparison between tissue and serum expression
Maria Jose Safont et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2011)
Adjuvant Chemotherapy for Stage II Colon Cancer With Poor Prognostic Features
Erin S. O'Connor et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Relationship between telomere shortening, genetic instability, and site of tumour origin in colorectal cancers
E. Rampazzo et al.
BRITISH JOURNAL OF CANCER (2010)
Human telomerase catalytic subunit (hTERT) suppresses p53-mediated anti-apoptotic response via induction of basic fibroblast growth factor
Xun Jin et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2010)
The Chromosomal Instability Pathway in Colon Cancer
Maria S. Pino et al.
GASTROENTEROLOGY (2010)
Microsatellite Instability in Colorectal Cancer
C. Richard Boland et al.
GASTROENTEROLOGY (2010)
Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon Cancer
Daniel J. Sargent et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial
Thierry Andre et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Colon Cancer
Paul F. Engstrom et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2009)
Molecular Origins of Cancer: Molecular Basis of Colorectal Cancer.
Sanford D. Markowitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Mechanisms of Disease: Telomere Diseases.
Rodrigo T. Calado et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
Eric Van Cutsem et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Telomere function in colorectal cancer
Cristina Frias et al.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2009)
Relationship Between Tumor and Plasma Levels of hTERT mRNA in Patients with Colorectal Cancer: Implications for Monitoring of Neoplastic Disease
Liliana Terrin et al.
CLINICAL CANCER RESEARCH (2008)
Real-time PCR quantification of human telomerase reverse transcriptase (hTERT) in colorectal cancer
Said Saleh et al.
PATHOLOGY (2008)
Photochemically enhanced delivery of a cell-penetrating peptide nucleic acid conjugate targeting human telomerase reverse transcriptase: effects on telomere status and proliferative potential of human prostate cancer cells
M. Folini et al.
CELL PROLIFERATION (2007)
Predictive value of microsatellite instability-high remains controversial
George P. Kim et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Targeting the limitless replicative potential of cancer: The telomerase/telomere pathway
Lloyd Kelland
CLINICAL CANCER RESEARCH (2007)
hTERT inhibits the Epstein-Barr virus lytic cycle and promotes the proliferation of primary B lymphocytes: Implications for EBV-driven lymphomagenesis
Liliana Terrin et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
hTERT: a novel endogenous inhibitor of the mitochondrial cell death pathway
C. Massard et al.
ONCOGENE (2006)
Association between MDM2-SNP309 and age at colorectal cancer diagnosis according to p53 mutation status
C Menin et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Correlations of telomere length, telomerase activity, and telomeric-repeat binding factor 1 expression in colorectal carcinoma - Prognostic indications
C Garcia-Aranda et al.
CANCER (2006)
Involvement of hTERT in apoptosis induced by interference with Bcl-2 expression and function
D Del Bufalo et al.
CELL DEATH AND DIFFERENTIATION (2005)
hTERT antagonizes p53-induced apoptosis independently of telomerase activity
R Rahman et al.
ONCOGENE (2005)
Telomerase activity as a prognostic factor in colorectal cancer
MT Sanz-Casla et al.
ONKOLOGIE (2005)
Normalization of gene expression measurements in tumor tissues: comparison of 13 endogenous control genes
JB de Kok et al.
LABORATORY INVESTIGATION (2005)
American society of clinical oncology recommendations on adjuvant chemotherapy for stage II colon cancer
AB Benson et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Telomere length and human telomerase reverse transcriptase expression as markers for progression and prognosis of colorectal carcinoma
R Gertler et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer:: Who benefits and by how much?
S Gill et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer
CM Ribic et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Early-age-at-onset colorectal cancer and microsatellite instability as markers of hereditary nonpolyposis colorectal cancer
S Pucciarelli et al.
DISEASES OF THE COLON & RECTUM (2003)
Activity and expression of human telomerase in normal and malignant cells in gastric and colon cancer patients
J Nowak et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2003)
Prognostic potential of the telomerase subunit human telomerase reverse transcriptase in tumor tissue and nontumorous mucosa from patients with colorectal carcinoma
R Gertler et al.
CANCER (2002)
Telomerase activity in stage II colorectal carcinoma - Telomerase-negative tumors are correlated with poor prognosis
R Kawanishi-Tabata et al.
CANCER (2002)
TERT regulates cell survival independent of telomerase enzymatic activity
Y Cao et al.
ONCOGENE (2002)
Transfer of the human telomerase reverse transcriptase (TERT) gene into T lymphocytes results in extension of replicative potential
N Rufer et al.
BLOOD (2001)
分享论文
